Evidence map›Paper›PMID 32678846›Full record

ArticlePLoS genetics2020

Protein-Protein interactions uncover candidate 'core genes' within omnigenic disease networks.

Abhirami Ratnakumar, Nils Weinhold, Jessica C Mar, Nadeem Riaz

Open access · goldFull text read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Introducing critical proteins related to liver ischemia/reperfusion injury.Gastroenterology and hepatology from bed to bench · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Multi-omics peripheral and core regions of cancer.NPJ systems biology and applications · 2022
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Abhirami RatnakumarDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.ORCID 0000-0001-9623-0377
Nils WeinholdDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.ORCID 0000-0003-3290-6192
Jessica C MarAustralian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Australia.
Nadeem RiazDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.ORCID 0000-0001-9873-5862
Memorial Sloan Kettering Cancer Center · USThe University of Queensland · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Genome wide association studies (GWAS) of human diseases have generally identified many loci associated with risk with relatively small effect sizes. The omnigenic model attempts to explain this observation by suggesting that diseases can be thought of as networks, where genes with direct involvement in disease-relevant biological pathways are named 'core genes', while peripheral genes influence disease risk via their interactions or regulatory effects on core genes. Here, we demonstrate a method for identifying candidate core genes solely from genes in or near disease-associated SNPs (GWAS hits) in conjunction with protein-protein interaction network data. Applied to 1,381 GWAS studies from 5 ancestries, we identify a total of 1,865 candidate core genes in 343 GWAS studies. Our analysis identifies several well-known disease-related genes that are not identified by GWAS, including BRCA1 in Breast Cancer, Amyloid Precursor Protein (APP) in Alzheimer's Disease, INS in A1C measurement and Type 2 Diabetes, and PCSK9 in LDL cholesterol, amongst others. Notably candidate core genes are preferentially enriched for disease relevance over GWAS hits and are enriched for both Clinvar pathogenic variants and known drug targets-consistent with the predictions of the omnigenic model. We subsequently use parent term annotations provided by the GWAS catalog, to merge related GWAS studies and identify candidate core genes in over-arching disease processes such as cancer-where we identify 109 candidate core genes.

Indexed as

Genome-Wide Association StudyAlzheimer DiseaseAmyloid beta-Protein PrecursorBRCA1 ProteinBreast NeoplasmsDiabetes Mellitus, Type 2FemaleHumansInsulinPolymorphism, Single NucleotideProprotein Convertase 9Protein Interaction MapsRisk FactorsAmyloid beta-Protein PrecursorAPP protein, humanBRCA1 ProteinBRCA1 protein, humanInsulinPCSK9 protein, humanProprotein Convertase 9

Identifiers

PMID32678846
PMCPMC7390454
OpenAlexW3042542048

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.